首页 | 本学科首页   官方微博 | 高级检索  
     

桂枝茯苓丸对子宫内膜异位症患者血清中IL-10和IL-17的影响
引用本文:苏春兰. 桂枝茯苓丸对子宫内膜异位症患者血清中IL-10和IL-17的影响[J]. 北方药学, 2015, 0(9): 97-97
作者姓名:苏春兰
作者单位:晋江市内坑卫生院妇产科 晋江 362300
摘    要:目的:了解桂枝茯苓丸对子宫内膜异位症(EMS)患者血清IL-10和IL-17水平的影响。方法:选取2013~2014年晋江市内坑卫生院妇产科子宫内膜异位症患者40例,所有患者均接受桂枝茯苓丸治疗,连续治疗1个月,应用ELISA法检测治疗前后患者血清中IL-10和IL-17表达的变化。结果:与治疗前比较,桂枝茯苓丸治疗后患者血清中IL-10和IL-17的表达水平明显下降(P<0.05)。结论:桂枝茯苓丸可能通过抑制IL-10和IL-17的表达从而起到对子宫内膜异位症的治疗作用。

关 键 词:桂枝茯苓丸  子宫内膜异位症  IL-10  IL-17

Influence of Guizhifulingwan on serum IL-10 and IL-17 in patients with endometriosis
Abstract:Objective:To explore the effects of Guizhifulingwan on the expressions of IL-10 and IL-17 in patients with endometriosis. Methods:A total of 40 endometriosis patients from 2013 to 2014 were included.All patients received treatment of Guizhifulingwan. After one month treatment, the levels of IL-10 and IL-17 were analyzed by ELISA. Results:Compared with pretreatment,the posttreatment levels of IL-10 and IL-17 were significantly reduced (P<0.05). Conclusion:The Guizhifulingwan can treat the endometriosis,one of the reasons may be associated with decreasing the expressions of IL-10 and IL-17 in ectopic endometrium.
Keywords:Guizhifulingwan  Endometriosis  IL-10  IL-17
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号